Dr. Boubacar Benziane obtained his PhD in 2006 under the supervision of Prof. Pascal Houillier at the Laboratory INSERM U652, Physiologie et pharmacologie vasculaire et rénale, Paris 6 University, France. During his PhD, he performed research in the field of renal molecular biology and unravelled mechanisms involving the role of membrane proteins in reabsorption of water in the kidney.
After his PhD, he joined the group of Dr. Alexander Chibalin at Karolinska Institutet, Stockholm, Sweden as a postdoctoral fellow. He has played a central role in demonstrating the role of AMPK in the regulation of Na+-K+-ATPase in skeletal muscle. During that period he also showed a side-effect of A-769662 on Na+-K+-ATPase. In parallel he was also working to understand the role of phospholemman in glucose/lipid metabolism.
In 2011 he obtained the position as an assistant professor in Prof. Juleen Zierath’s group at the department of Physiology and Pharmacology, Karolinska Institutet, Sweden. The goal of his research is to study the effects of several proteins in type II diabetes with in vivo and in vitro approaches. He was in charge of studying several genetically modifed animal models with the setup of a high fat diet study, using cell expertise to explain the physiological observations in these animal models.